Kalundborg in Denmark is a modern-day 'gold rush' town – but pharmaceutical giant Novo Nordisk has invested more than £6.5 billion and it still isn't booming
6
votes
Showing only topics with the tag "novo nordisk".
Back to normal view
-
-
Novo Nordisk is to invest more than $4bn in US manufacturing as it battles to keep up with booming demand for its obesity and diabetes drugs Wegovy and Ozempic
9 votes -
Denmark's economy contracts with drop in pharma production – Danish GDP fell 1.8% in the first quarter
7 votes -
How the entire country of Denmark became a company town – economists warn of "Nokia-style" overdependence on a single sector with Ozempic boom
4 votes -
Can Denmark's world-beating drugs maker Novo Nordisk stay ahead after Wegovy propelled them into the big league?
8 votes -
In the wake of substantial growth, Novo Nordisk's stock price climbs to near-peak levels – investors are asking whether the stock is now hovering in overvalued territory
6 votes -
Novo Nordisk suggested to senior UK government officials that they could “profile” benefit claimants – those who are most likely to return to the labour market
17 votes -
Denmark is building on the success of blockbuster drugs – the country's focus on reinvestment is feeding a stream of discovery
7 votes -
Something is golden in the state of Denmark – can Novo Nordisk's success really be a problem for the Danish economy?
8 votes -
With Novo Nordisk, Denmark wants to avoid the Nokia trap
14 votes -
Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country's economic growth
6 votes -
America's obsession with weight-loss drugs is affecting the economy of Denmark – Novo Nordisk's market capitalization has matched the GDP of its home country
17 votes -
How Sweden and Denmark became rare bright spots for Europe's pharma industry
3 votes -
The ‘breakthrough’ obesity drugs that have stunned researchers
17 votes